Featured Research

from universities, journals, and other organizations

Potent New Compound From Blue-Green Algae May Help Treat, Elucidate Nerve Disorders

Date:
December 20, 2000
Source:
American Chemical Society
Summary:
Amid a growing list of biologically useful chemicals from the sea, a newly discovered compound - kalkitoxin - stands out for its potential to help researchers understand nerve function, which could someday lead to new treatments for pain, epilepsy and possibly stroke.

HONOLULU, Dec. 19 - Amid a growing list of biologically useful chemicals from the sea, a newly discovered compound - kalkitoxin - stands out for its potential to help researchers understand nerve function, which could someday lead to new treatments for pain, epilepsy and possibly stroke. The finding was reported here today at the 2000 International Chemical Congress of Pacific Basin Societies.

The weeklong scientific meeting, held once every five years, is hosted by the American Chemical Society, in conjunction with its counterparts in Australia, Canada, Japan and New Zealand.

Lead investigator William Gerwick, Ph.D., a pharmacy professor at Oregon State University in Corvallis, says the neurotoxin - a metabolite in cyanobacteria - is fundamentally new in both structure and potency.

"What we've found is a spectacularly potent neurotoxin, meaning kalkitoxin can kill neurons," explained Gerwick. "And when a compound is very toxic, it's working by a very specific mechanism." He and his collaborators hope to use that mechanism "to dissect neurochemical pathways and to understand how drugs affect them," he said.

Their discovery began "in an absolutely beautiful bay" of the Caribbean island of Curacao, near Venezuela, Gerwick said. "In 1994, we found a collection of cyanobacteria growing like hairs off the sea floor. We brought several liters of it back to Oregon for testing." Marine cyanobacteria, also called blue-green algae, are most familiar to many people as "pond scum."

Back in the laboratory, Gerwick's team ground up samples of the simple plant and tested extracts on brine shrimp and fish. One extract proved toxic even in concentrations of parts per billion. The researchers named the as-yet-mysterious compound after the island's Kalki Bay and set to work tracking down its structure.

The project proved to be a challenge for the next several years. Kalkitoxin's three-dimensional structure "turned out to be particularly tricky," said Gerwick. "It turned out to have five stereo centers, and ones that are hard to reach."

Like hands, molecules can be identical in chemical composition - but the arrangement of their atoms in space can make them mirror images of each other. Such sites, or stereo centers, within a biologically active molecule often form the finely crafted pockets or arms with which it latches on to enzymes, nerve-cell receptors and other molecules in the body.

While kalkitoxin's purpose in cyanobacteria is still uncertain, said Gerwick, its target in animals appears to be sodium-ion channels. These pores within the membranes of neurons are voltage gates, he explained, the primary means by which neurons build up electrical charge. Kalkitoxin appears to block sodium channels, preventing the nerve cells from firing off their electrical signals.

Interestingly, drugs such as topiramate help suppress epileptic attacks largely by blocking sodium channels. Such painkillers as lidocaine are sodium-channel blockers as well. "These disorders, including neurodegenerative diseases, could be treated by selectively activating and blocking sodium channels," said Gerwick. "So even if kalkitoxin doesn't become a useful pharmaceutical itself, it's a valuable tool to understanding how the channels work and how disease and drugs affect them."

More than 8,000 research papers will be presented during this year's International Chemical Congress, which is sponsored jointly by the American Chemical Society, the Chemical Society of Japan, the Canadian Society of Chemistry, the Royal Australian Chemical Institute and the New Zealand Institute of Chemistry.

William Gerwick is a professor in the College of Pharmacy at Oregon State University in Corvallis, Ore.


Story Source:

The above story is based on materials provided by American Chemical Society. Note: Materials may be edited for content and length.


Cite This Page:

American Chemical Society. "Potent New Compound From Blue-Green Algae May Help Treat, Elucidate Nerve Disorders." ScienceDaily. ScienceDaily, 20 December 2000. <www.sciencedaily.com/releases/2000/12/001220080347.htm>.
American Chemical Society. (2000, December 20). Potent New Compound From Blue-Green Algae May Help Treat, Elucidate Nerve Disorders. ScienceDaily. Retrieved July 25, 2014 from www.sciencedaily.com/releases/2000/12/001220080347.htm
American Chemical Society. "Potent New Compound From Blue-Green Algae May Help Treat, Elucidate Nerve Disorders." ScienceDaily. www.sciencedaily.com/releases/2000/12/001220080347.htm (accessed July 25, 2014).

Share This




More Health & Medicine News

Friday, July 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Beatings and Addiction: Pakistan Drug 'clinic' Tortures Patients

Beatings and Addiction: Pakistan Drug 'clinic' Tortures Patients

AFP (July 24, 2014) A so-called drugs rehab 'clinic' is closed down in Pakistan after police find scores of ‘patients’ chained up alleging serial abuse. Duration 03:05 Video provided by AFP
Powered by NewsLook.com
Too Few Teens Receiving HPV Vaccination, CDC Says

Too Few Teens Receiving HPV Vaccination, CDC Says

Newsy (July 24, 2014) The Centers for Disease Control and Prevention is blaming doctors for the low number of children being vaccinated for HPV. Video provided by Newsy
Powered by NewsLook.com
New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins